Tag: CI/CD

As a biotechnology company, Stoke Therapeutics is dedicated to addressing the underlying cause of severe diseases with RNA-based medicines. Identifying genomic signatures begins with computational analyses of publicly-available archived data and privately-generated sequencing data. Through AWS, Stoke has quick access to computing resources without the active management of on-prem hardware, enabling them to close the gap between sequencing and interpretation and dedicate more time to science.